Cooking Classes for Chinese Canadian Patients Living With Diabetes

Status Completed

Clinical Trial Summary

This study aims to determine whether providing language and culturally appropriate cooking classes to Chinese Canadian individuals with diabetes will help to improve their diabetes control, knowledge and self care activities. The control group will receive current standard care of two diabetes education classes led by the dietitian and nurse. The intervention group will receive standard care and a series of four interactive cooking classes led by a dietitian, nurse and chef. We will compare the results of blood work, knowledge and self care questionnaires between the two groups to determine whether there are any benefits to attending these cooking classes.

Clinical Trial Description

This is a study attempting to investigate whether a cooking class intervention will lead to improved glycemic control in Chinese-Canadian people in the community of Richmond, British Columbia. By providing culturally appropriate cooking classes, tailored to Chinese foods, culture and population, we will be able to address specific challenges that affect ethnic Chinese patients with diabetes living in Canada. This innovative program would serve to meet a need that is currently unmet in the community, by providing a hands-on opportunity for participants to try different foods, learn various culturally appropriate recipes, prepare meals together and learn how the foods being eaten affects blood glucose. These classes would also serve as an avenue to reinforce various diabetes self-management activities - including self-monitoring of blood glucose and the effects of physical activity. Also, participants may benefit from peer support and the sharing of experiences and advice with each other. Through this research study, we hope to demonstrate improved diabetes knowledge, self-care management and glycemic control for patients who attend the cooking classes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02666924
Study type	Interventional
Source	Vancouver General Hospital
Contact
Status	Completed
Phase	N/A
Start date	October 31, 2017
Completion date	December 31, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01267448` - Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia	Phase 4
Active, not recruiting	`NCT05330247` - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study	N/A
Terminated	`NCT02743598` - Liraglutide for HIV-associated Neurocognitive Disorder	Phase 4
Terminated	`NCT02373865` - Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes	Phase 4
Completed	`NCT01741181` - Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2	Phase 4
Completed	`NCT01305434` - Mulberry Leaf Extract and Blood Glucose Control in Diabetics	Phase 1/Phase 2
Completed	`NCT01330121` - Bridging the Gap by Transitional Care	N/A
Recruiting	`NCT00992797` - Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity	Phase 2
Completed	`NCT01580904` - Impact of Pharmaceutical Care in Diabetics Patients	N/A
Active, not recruiting	`NCT00728403` - Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes	Phase 2
Completed	`NCT00763815` - GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone	Phase 3
Active, not recruiting	`NCT00529815` - Continuous Glucose Monitoring in Patients With Type 2 Diabetes	Phase 4
Completed	`NCT00517465` - A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.	Phase 1
Completed	`NCT00119041` - Diabetes Telemedicine Consultation: A Systems Improvement Intervention	N/A
Withdrawn	`NCT00417716` - Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema	Phase 3
Withdrawn	`NCT00600236` - HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population	Phase 3
Active, not recruiting	`NCT05887635` - Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus	N/A
Completed	`NCT03903965` - Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.
Recruiting	`NCT02501850` - The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)	Phase 4
Completed	`NCT02001480` - Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Cooking Classes for Chinese Canadian Patients Living With Diabetes — CCDS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms